No Data
No Data
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--$MORF #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Morphic Holding, Inc. ("Morphic" or
Morphic Holding Insiders Placed Bullish Bets Worth US$47.3m
Morphic Holding Names Simon Cooper as Chief Medical Officer
Morphic Holding (MORF) said Tuesday that Simon Cooper has joined the company as its chief medical officer. Cooper previously held the same role at Keros Therapeutics (KROS), according to Morphic. Pric
Morphic Appoints Simon Cooper as CMO
Morphic Appoints Simon Cooper As Chief Medical Officer
Press Release: Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory Diseases WALTHAM, Mass., March 19, 2024 (GLOBE
No Data